Targets | Drugs | Clinical phase | Conditions | Sponsor | Gov identifier |
---|---|---|---|---|---|
Tyrosine kinase | PLX3397 | 1 | Prostate adenocarcinoma | Barbara Ann Karmanos Cancer Institute | NCT02472275 |
Cholesterol | Tesco | Not applicable | Breast cancer | University of Leeds | NCT04147767 |
mTOR | Sirolimus | 1/2 | Pancreatic cancer | Second Affiliated Hospital, School of Medicine, Zhejiang University | NCT03662412 |
Glucose metabolism | Metformin | 2 | Breast cancer | Oxford University Hospitals NHS Trust | NCT01266486 |
 |  | 1 | Head and neck squamous cell cancer | Sidney Kimmel Cancer Center at Thomas Jefferson University | NCT02083692 |
 |  | 1 | Cancer of head and neck | West Virginia University | NCT02402348 |
 |  | 2 | Lung cancer | M.D. Anderson Cancer Center | NCT02285855 |
 |  | 1 | Endometrial cancer | M.D. Anderson Cancer Center | NCT01205672 |
 | 2-DG | 1/2 | Prostate cancer | Rutgers, The State University of New Jersey | NCT00633087 |
 |  |  | Intracranial neoplasms |  | NCT00247403 |
 |  |  | Neoplasm metastasis |  |  |
PPARγ | Rosiglitazone | 2 | Melanoma | Dan Zandberg | NCT04114136 |
 |  |  | Nsclc |  |  |
 |  |  | Hepatocellular carcinoma |  |  |
 | Dichloroacetate | 1 | Head and neck cancer | Daniel T. Chang | NCT01163487 |
 | Pioglitazone | 2 | Cancer of the pancreas | University of Texas Southwestern Medical Center | NCT01838317 |
Cholesterol | Evolocumab | 1 | Pancreatic ductal adenocarcinoma | CHU de Quebec-Universite Laval | NCT04862260 |
 |  | 1 | Glioblastoma | Duke University | NCT04937413 |
 | Atorvastatin |  | Pancreatic cancer |  |  |
 | Ezetimibe |  | Pancreas cancer |  |  |
 |  |  | Metastatic cancer |  |  |
HMG-CoA reductase | Rosuvastatin | 4 | Prostate cancer metastatic | National Cancer Institute, Egypt | NCT04776889 |
Arginase | INCB001158 | 1/2 | Metastatic cancer | Incyte Corporation | NCT02903914 |
 |  |  | Solid tumours |  |  |
 |  |  | Colorectal cancer |  |  |
 |  |  | Gastric cancer |  |  |
 |  | 1 | Advanced solid tumours | Advanced solid tumours | NCT03910530 |
 |  |  | Advanced solid tumours |  |  |
 |  | 1/2 | Biliary tract cancer | Incyte Corporation | NCT03314935 |
 |  |  | Colorectal cancer |  |  |
 |  |  | Endometrial cancer |  |  |
 |  | 1/2 | Solid tumours | Incyte Corporation | NCT03361228 |